Previous 10 | Next 10 |
Abcam plc (ABCZF) 2021 Interim Earnings Conference Call March 8, 2021 9:00 am ET Company Participants Alan Hirzel - Chief Executive Officer Michael Baldock - Chief Financial Officer James Stavely - Vice President, Investor Relations Conference Call Participants Tejas Sevant - Morgan Stanley C...
The following slide deck was published by Abcam plc in conjunction with their 2021 Q2 earnings call. For further details see: Abcam plc 2021 Q2 - Results - Earnings Call Presentation
CAMBRIDGE, United Kingdom, March 08, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (“ Abcam ”, the “ Group ” or the “ Company ”), a global leader in the supply of life science research tools, today announces its interim res...
Scaling up R&D, manufacturing and commercial capabilities in Shanghai and Hangzhou Investing in state-of-the-art facilities and equipment to support research, diagnostic and clinical applications CAMBRIDGE, United Kingdom, March 04, 2021 (GLOBE NEWSWIRE) -- Today A...
CAMBRIDGE, United Kingdom, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“ Abcam ” or the “ Company ”), a global leader in the supply of life science research tools, will report its Interim Results for the six-month period ended 31...
CAMBRIDGE, United Kingdom, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; LSE: ABC) today announced that Alan Hirzel, Chief Executive Officer, will present at the 2021 SVB Leerink Global Healthcare Conference on Friday, February 26, 2021 at 8.00 EST / 13.00 GMT. A live webcast o...
CAMBRIDGE, United Kingdom, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“ Abcam ”), a global leader in the supply of life science research tools, is delighted to announce the appointments of Bessie Lee and Mark Capone as non-executive Directors wit...
Abcam has a strong position in the niche of supplies for antibody research. It is profitable, dividend paying, and continues to grow well. But the valuation looks high. I avoid. For further details see: Abcam: An Attractive, Profitable Medtech But Pricy
Abcam ([[ABCM]] +6.5%) expects its total 1H revenue of £147.5M, representing growth of 6.7%Y/Y and 8.3% on a constant currency basis.In-house products represented over 55% of total revenue and grew by over 25%. On a constant currency basis, catalogue revenue, representing 95% o...
CAMBRIDGE, United Kingdom, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“ Abcam ”), a global leader in the supply of life science research tools, announces the following unaudited trading update ahead of reporting its results on 8 March 2021 for th...
News, Short Squeeze, Breakout and More Instantly...
Danaher Completes Acquisition of Abcam PR Newswire WASHINGTON , Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam for $24.0...
Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (NYSE: DHR) ...
2023-11-19 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...